In the past years, many (randomized) trials have been performed comparing the treatment
strategies for lupus nephritis. In 2012, these data were incorporated in six different …

Despite the negative outcome of recent trials there is growing evidence that there are
increasing opportunities in patients with lupus nephritis to offer treatments tailored to the …

Objectives To develop recommendations for the management of adult and paediatric lupus
nephritis (LN). Methods The available evidence was systematically reviewed using the …

Lupus nephritis (LN) is one of the most common manifestations of systemic lupus
erythematosus (SLE), affecting approximately 40% of patients with lupus. It represents a …

Lupus nephritis (LN) occurs in 50%–60% of patients with childhood-onset systemic lupus
erythematosus (cSLE), leading to significant morbidity. Timely recognition of renal …

Management of lupus nephritis has evolved considerably over the past years. Here, we
provide a comprehensive review of clinical trials that form the basis for the Kidney Disease …

Lupus nephritis (LN) is more common and severe in childhood-onset systemic lupus
erythematosus (SLE) than in adults. It is one of the major causes of acute kidney injury (AKI) …

The care of children with lupus nephritis (LN) has changed dramatically over the past 50 y.
The majority of patients with childhood-onset systemic lupus erythematosus (cSLE) develop …

Background Lupus nephritis is the renal manifestation of systemic lupus erythematosus
(SLE)‐a disease mainly affecting young women with substantial morbidity and mortality. It is …

Childhood-onset systemic lupus erythematosus (cSLE) is a severe multisystem autoimmune
disease. Renal involvement occurs in the majority of cSLE patients and is often fatal. Renal …